Pharma Markets

Global Psoriasis Market and Competitive Landscape

By Fore Pharma | Published Date: June 7, 2020 | On-Demand Data

The latest research from Fore Pharma, Global Psoriasis Market and Competitive Landscape – 2020, provides comprehensive insights into Psoriasis pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecast Psoriasis market size and drug sales. It also provides insights into Psoriasis epidemiology and late stage pipeline.

This research covers the following – Psoriasis treatment options, Psoriasis late stage clinical trials pipeline, Psoriasis prevalence by countries, Psoriasis market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).

Research Scope:

– Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
– Psoriasis pipeline: Find out drugs in clinical trials for Psoriasis by development phase 3, phase 2, and phase 1, by pharmacological class and company
– Psoriasis epidemiology: Find out number of patients diagnosed (prevalence) with Psoriasis by countries
– Psoriasis drugs: Identify key drugs marketed and prescribed for Psoriasis by countries, including trade name, molecule name, and company
– Psoriasis drugs sales: Find out the sales value for Psoriasis drugs by countries
– Psoriasis market valuations: Find out the market size for Psoriasis drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2025
– Psoriasis drugs market share: Find out the market shares for key drugs by countries

Benefits of this Research: The research helps executives to

– Evaluate commercial market opportunities for Psoriasis drugs
– Synthesize insights for business development & licensing
– Track market size, competitor drug sales, market shares in Psoriasis market
– Develop in-depth knowledge of competition and markets
– Analyze Psoriasis drug sales data to update your brand planning trackers
– Develop tactics and strategies to take advantage of opportunities in the market
– Track Market Events and Trends and analyze key events in Psoriasis market
– Develop forecast models, healthcare frameworks, or economic models
– Answer key business questions; supports decision making in R&D to long term marketing strategies

Table of Contents


1. Psoriasis Treatment Options
2. Psoriasis Pipeline Insights
2.1. Psoriasis Phase 3 Clinical Trials
2.2. Psoriasis Phase 2 Clinical Trials
2.3. Psoriasis Phase 1 Clinical Trials
3. Psoriasis Epidemiology Analysis by Countries
4. US Psoriasis Market Insights
4.1. Marketed Drugs for Psoriasis in US
4.2. US Psoriasis Market Size & Forecast
4.3. US Psoriasis Drugs Sales & Forecast
4.4. US Psoriasis Market Share Analysis
5. Germany Psoriasis Market Insights
5.1. Marketed Drugs for Psoriasis in Germany
5.2. Germany Psoriasis Market Size & Forecast
5.3. Germany Psoriasis Drugs Sales Forecast
5.4. Germany Psoriasis Market Share Analysis
6. France Psoriasis Market Insights
6.1. Marketed Drugs for Psoriasis in France
6.2. France Psoriasis Market Size & Forecast
6.3. France Psoriasis Product Sales Forecast
6.4. France Psoriasis Market Share Analysis
7. Italy Psoriasis Market Insights
7.1. Marketed Drugs for Psoriasis in Italy
7.2. Italy Psoriasis Market Size & Forecast
7.3. Italy Psoriasis Product Sales Forecast
7.4. Italy Psoriasis Market Share Analysis
8. Spain Psoriasis Market Insights
8.1. Marketed Drugs for Psoriasis in Spain
8.2. Spain Psoriasis Market Size & Forecast
8.3. Spain Psoriasis Product Sales Forecast
8.4. Spain Psoriasis Market Share Analysis
9. UK Psoriasis Market Insights
9.1. Marketed Drugs for Psoriasis in UK
9.2. UK Psoriasis Market Size & Forecast
9.3. UK Psoriasis Product Sales Forecast
9.4. UK Psoriasis Market Share Analysis
10. Europe Psoriasis Market Insights
10.1. Europe Psoriasis Market Size & Forecast
10.2. Europe Psoriasis Product Sales Forecast
10.3. Europe Psoriasis Market Share Analysis
11. Japan Psoriasis Market Insights
11.1. Marketed Drugs for Psoriasis in Japan
11.2. Japan Psoriasis Market Size & Forecast
11.3. Japan Psoriasis Product Sales Forecast
11.4. Japan Psoriasis Market Share Analysis
12. Global Psoriasis Market Insights
12.1. Global Psoriasis Market Size & Forecast
12.2. Global Psoriasis Product Sales Forecast
12.3. Global Psoriasis Market Share Analysis
13. Research Methodology

List of Tables


1: Psoriasis Phase 3 Clinical Trials, Global, 2020
2: Psoriasis Phase 2 Clinical Trials, Global, 2020
3: Psoriasis Phase 1 Clinical Trials, Global, 2020
4: Psoriasis Prevalence by Countries, 2016 – 2025
5: Marketed Drugs for Psoriasis in US, 2019
6: US Psoriasis Market Size & Forecast ($mn), 2016 – 2025
7: US Psoriasis Product Sales ($mn), 2016 – 2025
8: US Psoriasis Market Events and Trends, 2016 – 2025
9: Marketed Drugs for Psoriasis in Germany, 2019
10: Germany Psoriasis Market Size & Forecast ($mn), 2016 – 2025
11: Germany Psoriasis Product Sales ($mn), 2016 – 2025
12: Germany Psoriasis Market Events and Trends, 2016 – 2025
13: Marketed Drugs for Psoriasis in France, 2019
14: France Psoriasis Market Size & Forecast ($mn), 2016 – 2025
15: France Psoriasis Product Sales ($mn), 2016 – 2025
16: France Psoriasis Market Events and Trends, 2016 – 2025
17: Marketed Drugs for Psoriasis in Italy, 2019
18: Italy Psoriasis Market Size & Forecast ($mn), 2016 – 2025
19: Italy Psoriasis Product Sales ($mn), 2016 – 2025
20: Italy Psoriasis Market Events and Trends, 2016 – 2025
21: Marketed Drugs for Psoriasis in Spain, 2019
22: Spain Psoriasis Market Size & Forecast ($mn), 2016 – 2025
23: Spain Psoriasis Product Sales ($mn), 2016 – 2025
24: Spain Psoriasis Market Events and Trends, 2016 – 2025
25: Marketed Drugs for Psoriasis in UK, 2019
26: UK Psoriasis Market Size & Forecast ($mn), 2016 – 2025
27: UK Psoriasis Product Sales ($mn), 2016 – 2025
28: UK Psoriasis Market Events and Trends, 2016 – 2025
29: Europe Psoriasis Market Size & Forecast ($mn), 2016 – 2025
30: Europe Psoriasis Product Sales ($mn), 2016 – 2025
31: Marketed Drugs for Psoriasis in Japan, 2019
32: Japan Psoriasis Market Size & Forecast ($mn), 2016 – 2025
33: Japan Psoriasis Product Sales ($mn), 2016 – 2025
34: Japan Psoriasis Market Events and Trends, 2016 – 2025
35: Global Psoriasis Market Size & Forecast ($mn), 2016 – 2025
36: Global Psoriasis Product Sales ($mn), 2016 – 2025

List of Figures


1: Psoriasis Pipeline by Phase (%), Global, 2020
2: Psoriasis Prevalence by Countries, 2016 – 2025
3: US Psoriasis Market Size ($mn), 2016 – 2025
4: US Psoriasis Product Sales ($mn), 2016 – 2025
5: US Psoriasis Market Share by Drugs (%), 2019
6: US Psoriasis Market – Future Market Share (%), 2025
7: Germany Psoriasis Market Size ($mn), 2016 – 2025
8: Germany Psoriasis Product Sales ($mn), 2016 – 2025
9: Germany Psoriasis Market Share by Drugs (%), 2019
10: Germany Psoriasis Market – Future Market Share (%), 2025
11: France Psoriasis Market Size ($mn), 2016 – 2025
12: France Psoriasis Product Sales ($mn), 2016 – 2025
13: France Psoriasis Market Share by Drugs (%), 2019
14: France Psoriasis Market – Future Market Share (%), 2025
15: Italy Psoriasis Market Size ($mn), 2016 – 2025
16: Italy Psoriasis Product Sales ($mn), 2016 – 2025
17: Italy Psoriasis Market Share by Drugs (%), 2019
18: Italy Psoriasis Market – Future Market Share (%), 2025
19: Spain Psoriasis Market Size ($mn), 2016 – 2025
20: Spain Psoriasis Product Sales ($mn), 2016 – 2025
21: Spain Psoriasis Market Share by Drugs (%), 2019
22: Spain Psoriasis Market – Future Market Share (%), 2025
23: UK Psoriasis Market Size ($mn), 2016 – 2025
24: UK Psoriasis Product Sales ($mn), 2016 – 2025
25: UK Psoriasis Market Share by Drugs (%), 2019
26: UK Psoriasis Market – Future Market Share (%), 2025
27: Europe Psoriasis Market Size ($mn), 2016 – 2025
28: Europe Psoriasis Product Sales ($mn), 2016 – 2025
29: Europe Psoriasis Market Share by Drugs (%), 2019
30: Europe Psoriasis Market – Future Market Share (%), 2025
31: Japan Psoriasis Market Size ($mn), 2016 – 2025
32: Japan Psoriasis Product Sales ($mn), 2016 – 2025
33: Japan Psoriasis Market Share by Drugs (%), 2019
34: Japan Psoriasis Market – Future Market Share (%), 2025
35: Global Psoriasis Market Size ($mn), 2016 – 2025
36: Global Psoriasis Product Sales ($mn), 2016 – 2025
37: Global Psoriasis Market Share by Drugs (%), 2019
38: Global Psoriasis Market – Future Market Share (%), 2025

Format


Dispatch format is XLSX.

Purchase Checkout Added to cart
face
  • Contact Nick
  •  Email
  •  Contact
  • I was looking for specific epidemiology and utilization data for our emerging therapy situation analysis. It was time sensitive. Your team helped me with the right data and methodologies. Thank you very much.
    - Director, Big Pharma

    About

    • About us
    • Research Store
    • Research Store
    • News
    • Contact

    Trusted By
    Top Companies